Those biomarkers cover mainly the presence of certain immune cell populations, such as cytotoxic T cells in the tumor microenvironment, as well as the expression of immune checkpoint molecules, such as PD1 and PD-L1 on these immune cells or on the respective tumor cells (6, 7). Here, CD274 is linked to neoplasm.